Benoît Adelus


Benoît Adelus has been a Strategic Partner of ArchiMed since inception in 2014, and became a Partner in 2018. He has over 30 years of experience within the Animal Health / Medtech / IVD (In Vitro Diagnostics) sectors in senior leadership roles across different geographies. Prior to joining ArchiMed, Benoît led, as CEO, bioMérieux and Sebia, two global leaders in specific IVD sub-sectors. Benoît successfully managed three LBOs as CEO of Sebia. Prior to that, Benoit served as COO at Merial, the animal pharma and vaccine leader.

Benoît has a long-standing relationship with other ArchiMed partners, since 2005. He also was a non-executive Director in the first investment of ArchiMed, in the trauma orthopaedics company Medistream / Citieffe. He is currently a non-executive Director in the UK-headquartered Hospital Equipment company DHG, specialized in Pressure Area Care equipment.

Benoît graduated with a doctorate in Veterinary Medicine from the Ecole Nationale Vétérinaire de Nantes and holds an MBA from HEC. Benoît is a French citizen. At ArchiMed, Benoît is particularly focused on the Diagnostics sector.